112 related articles for article (PubMed ID: 26716812)
1. The Role of Type I Interferon Subtypes and Interferon-Gamma in Type I Interferon Diabetes Inhibitory Activity in the NOD Mouse.
Sobel D; Ahvazi B; Pontzer C
J Interferon Cytokine Res; 2016 Apr; 36(4):238-46. PubMed ID: 26716812
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide decreases MHC class II but not MHC class I expression and increases intercellular adhesion molecule-1 structures in non-obese diabetic mouse pancreas.
Papaccio G; Ammendola E; Pisanti FA
J Endocrinol; 1999 Mar; 160(3):389-400. PubMed ID: 10076185
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse.
Sobel DO; Han J; Williams J; Yoon JW; Jun HS; Ahvazi B
J Autoimmun; 2002 Nov; 19(3):129-37. PubMed ID: 12419283
[TBL] [Abstract][Full Text] [Related]
4. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
5. Interferon-tau inhibits the development of diabetes in NOD mice.
Sobel DO; Ahvazi B; Amjad F; Mitnaul L; Pontzer C
Autoimmunity; 2008 Nov; 41(7):543-53. PubMed ID: 18608174
[TBL] [Abstract][Full Text] [Related]
6. Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.
Zhao Y; Scott NA; Quah HS; Krishnamurthy B; Bond F; Loudovaris T; Mannering SI; Kay TW; Thomas HE
Eur J Immunol; 2015 Sep; 45(9):2494-503. PubMed ID: 25959978
[TBL] [Abstract][Full Text] [Related]
7. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
8. Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.
Xiang M; Zaccone P; Di Marco R; Harris R; Magro G; Di Mauro M; Meroni PL; Garotta G; Nicoletti F
Autoimmunity; 1999; 30(2):71-80. PubMed ID: 10435719
[TBL] [Abstract][Full Text] [Related]
9. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
[TBL] [Abstract][Full Text] [Related]
10. Human parainfluenza virus type 3 inhibits gamma interferon-induced major histocompatibility complex class II expression directly and by inducing alpha/beta interferon.
Gao J; De BP; Han Y; Choudhary S; Ransohoff R; Banerjee AK
J Virol; 2001 Feb; 75(3):1124-31. PubMed ID: 11152485
[TBL] [Abstract][Full Text] [Related]
11. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
13. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
[TBL] [Abstract][Full Text] [Related]
14. Strain-specific variation in constitutive and inducible expression of MHC class II, class I and ICAM-1 on rat cerebral endothelium.
Linke AT; Male DK
Immunology; 1994 May; 82(1):88-94. PubMed ID: 7913916
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
16. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
[TBL] [Abstract][Full Text] [Related]
17. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells.
Banu N; Meyers CM
Kidney Int; 1999 Jun; 55(6):2250-63. PubMed ID: 10354273
[TBL] [Abstract][Full Text] [Related]
19. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
20. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
